1. Home
  2. CVRX vs SOR Comparison

CVRX vs SOR Comparison

Compare CVRX & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • SOR
  • Stock Information
  • Founded
  • CVRX 2000
  • SOR 1968
  • Country
  • CVRX United States
  • SOR United States
  • Employees
  • CVRX N/A
  • SOR N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SOR Investment Managers
  • Sector
  • CVRX Health Care
  • SOR Finance
  • Exchange
  • CVRX Nasdaq
  • SOR Nasdaq
  • Market Cap
  • CVRX 419.8M
  • SOR 328.9M
  • IPO Year
  • CVRX 2021
  • SOR N/A
  • Fundamental
  • Price
  • CVRX $7.78
  • SOR $41.94
  • Analyst Decision
  • CVRX Strong Buy
  • SOR
  • Analyst Count
  • CVRX 6
  • SOR 0
  • Target Price
  • CVRX $17.60
  • SOR N/A
  • AVG Volume (30 Days)
  • CVRX 315.7K
  • SOR 16.2K
  • Earning Date
  • CVRX 05-08-2025
  • SOR 01-01-0001
  • Dividend Yield
  • CVRX N/A
  • SOR 7.24%
  • EPS Growth
  • CVRX N/A
  • SOR N/A
  • EPS
  • CVRX N/A
  • SOR 6.50
  • Revenue
  • CVRX $51,292,000.00
  • SOR N/A
  • Revenue This Year
  • CVRX $22.17
  • SOR N/A
  • Revenue Next Year
  • CVRX $24.02
  • SOR N/A
  • P/E Ratio
  • CVRX N/A
  • SOR $6.41
  • Revenue Growth
  • CVRX 30.53
  • SOR N/A
  • 52 Week Low
  • CVRX $5.81
  • SOR $36.41
  • 52 Week High
  • CVRX $18.55
  • SOR $42.75
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 46.08
  • SOR 57.17
  • Support Level
  • CVRX $7.30
  • SOR $41.11
  • Resistance Level
  • CVRX $8.28
  • SOR $42.58
  • Average True Range (ATR)
  • CVRX 0.49
  • SOR 1.03
  • MACD
  • CVRX 0.32
  • SOR 0.14
  • Stochastic Oscillator
  • CVRX 79.76
  • SOR 76.53

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About SOR Source Capital Inc.

Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.

Share on Social Networks: